Nikhila Thammineni

Nikhila Thammineni practices at Rust Pmg Cardiology - HOPD in Rio Rancho, New Mexico.

Nikhila Thammineni's NPI, 1487150330, was assigned on March 31, 2018. Nikhila Thammineni holds New Mexico license MD2023-1487.

Nikhila Thammineni's primary practice is Rust Pmg Cardiology - HOPD, at 2400 Unser Blvd SE, Rio Rancho, NM 87124.

Nikhila Thammineni's primary practice is Rust Pmg Cardiology - HOPD in Rio Rancho, New Mexico. Nikhila Thammineni is also affiliated with Presbyterian Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Nikhila Thammineni to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nikhila Thammineni practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Nikhila Thammineni's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Nikhila Thammineni is licensed in New Mexico.

CMS data shows 104 Medicare services from Nikhila Thammineni across 3 procedure codes in 2024, for 58 Medicare patients. Medicare paid $8,504 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 58 Medicare patients who saw Nikhila Thammineni in 2024. The largest group is 65 to 74, with 23 patients. 60% of them have high cholesterol, and 55% have cancer. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nikhila Thammineni's median patient age at 69, with 65% women.

In 2024, Nikhila Thammineni wrote 247 Medicare Part D claims for 85 patients. 89% of them were for generic drugs. CMS names the drug for 105 of them, across 6 drugs with 11 or more claims each, at $20,380 in total drug cost. In 2020, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Nikhila Thammineni for performance year 2024, reported as part of a group. Nikhila Thammineni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Nikhila Thammineni as offering telehealth.

Dmand AI links 5 papers to Nikhila Thammineni in 2019. 2019 was the busiest year, with 3. Nikhila Thammineni's most frequent co-authors are Pradeep Reddy Kathi, MD, Murray Norman Ehrinpreis, MD and Kunwardeep Dhillon, MD.

CMS Open Payments shows 52 general payments to Nikhila Thammineni from 29 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 94% of the total. Daiichi Sankyo Inc. paid the most, $99.